A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling
Toxins · 2024
DOI: 10.3390/toxins16010030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Hodan Ibrahim und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston Campus, Preston PR1 2HE, UK. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ipsen, IPSEN bio innovation.
Abstract (Originalsprache)
Botulinum neurotoxin A (BoNT/A) is a potent neurotoxin that silences cholinergic neurotransmission through the cleavage of the synaptic protein SNAP-25. Previous studies have shown that, in addition to its paralytic effects, BoNT/A can inhibit sensory nerve activity. The aim of this study was to identify how BoNT/A inhibits afferent signalling from the bladder. To investigate the role of SNAP-25 cleavage in the previously reported BoNT/A-dependent inhibition of sensory signalling, we developed a recombinant form of BoNT/A with an inactive light chain, rBoNT/A (0), unable to paralyse muscle. We also developed recombinant light chain (LC)-domain-only proteins to better understand the entry mechanisms, as the heavy chain (HC) of the protein is responsible for the internalisation of the light chain. We found that, despite a lack of catalytic activity, rBoNT/A (0) potently inhibited the afferent responses to bladder distension to a greater degree than catalytically active rBoNT/A. This was also clear from the testing of the LC-only proteins, as the inactive rLC/A (0) protein inhibited afferent responses significantly more than the active rLC/A protein. Immunohistochemistry for cleaved SNAP-25 was negative, and purinergic and nitrergic antagonists partially and totally reversed the sensory inhibition, respectively. These data suggest that the BoNT/A inhibition of sensory nerve activity in this assay is not due to the classical well-characterised ‘double-receptor’ mechanism of BoNT/A, is independent of SNAP25 cleavage and involves nitrergic and purinergic signalling mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston Campus, Preston PR1 2HE, UK.
- Ipsen, Abingdon OX14 4RY, UK.
- Ipsen, 5 av Canada, 91940 Les Ulis, France.
ORCID-Profile: Kevin Retailleau, Jacquie Maignel, Matthew Beard, Donna Marie Daly
Förderung
- ipsen
- IPSEN bio innovation
Zitieren
APA
Ibrahim, H., Retailleau, K., Hornby, F., Maignel, J., Beard, M., & Daly, D. M. (2024). A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling. Toxins. https://doi.org/10.3390/toxins16010030
Vancouver
Ibrahim H, Retailleau K, Hornby F, Maignel J, Beard M, Daly DM. A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling. Toxins. 2024. doi:10.3390/toxins16010030
BibTeX
@article{Ibrahim2024,
author = {Ibrahim, Hodan and Retailleau, Kevin and Hornby, Fraser and Maignel, Jacquie and Beard, Matthew and Daly, Donna Marie},
title = {A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16010030}
}
EUVIMED